RXRXRecursion Pharmaceuticals, Inc.
+8.1% today · −17.6% over a year
1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 4% of the instruments we score
Quality, Stability: among the weakest; priced higher than most peers. No dividend.
Recursion Pharmaceuticals, Inc. (RXRX) valuation against sector peers: P/B 2.6, free-cash-flow yield −13.2%, P/S 34.7.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | RXRX | Sector median | vs median |
|---|---|---|---|
| P/E | — | 30.9 · n=159 | — |
| P/B | 2.6 | 4.0 · n=307 | 34% below |
| P/S | 34.7 | 4.1 · n=299 | 740% above |
| EV/EBIT | — | 25.6 · n=146 | — |
| Free-cash-flow yield | −13.2% | 1.4% · n=288 | 1,013% below |
| Dividend yield | 0.00% | 0.00% · n=362 | — |
| Return on equity | −48.7% | −2.1% · n=308 | — |
| Return on invested capital | −127.6% | 0.6% · n=282 | 19,896% below |
| Gross margin | 29.2% | 63.3% · n=205 | 54% below |
| Net debt / EBITDA | — | 1.27 · n=151 | — |
Value factor: 7 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 48.2 | 33.0 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 42.2 | 8.3 | — | 3.0% | 1.9% | 8/10 |
| ABBVAbbVie | 50.3 | — | 27.7 | 3.6% | 2.9% | 6/10 |
| MRKMerck | 149.5 | 8.2 | — | 4.0% | 2.3% | 8/10 |
| UNHUnitedHealth | 22.4 | 3.4 | 17.1 | 6.4% | 2.3% | 10/10 |
| TMOThermo Fisher Scientific | 37.8 | 4.9 | 35.7 | 2.8% | 0.3% | 9/10 |
| AMGNAmgen | 26.8 | 17.5 | 23.2 | 3.8% | 2.1% | 8/10 |
| GILDGilead Sciences | — | 16.1 | — | 6.6% | 1.9% | 5/10 |
| ABTAbbott | 40.7 | 3.8 | 32.9 | 3.5% | 2.8% | 6/10 |
| PFEPfizer | 41.3 | 1.9 | — | 7.1% | 7.4% | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 02 Nov 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.